News & Updates

The novel highly selective mineralocorticoid receptor blocker esaxerenone holds promise in the treatment of nocturnal hypertension, yielding substantial reductions in night-time blood pressure (BP), especially in Japanese patients with a riser pattern, as well as in N-terminal pro B-type natriuretic peptide (NT-proBNP) levels, according to a post hoc analysis of a phase III study.

A peak systolic blood pressure (SBP) at clinical exercise testing that is slightly lower than the predicted value appears predictive of future cardiovascular disease (CVD) and mortality, suggests a study. Higher peak SBP, however, is not associated with such risks.

About 10 percent of patients with the coronavirus disease 2019 (COVID-19) will suffer from upper extremity deep vein thrombosis despite adequate prophylaxis, a recent study has found.

While tranexamic acid improves blood control after coronary artery bypass graft (CABG) surgery, it increases the risk of perioperative myocardial infarction, a recent study has found.

Increased levels of dietary sodium (Na) intake and load (Na-L) appear to cause arterial stiffness, a preclinical measure of cardiovascular disease (CVD), in children and young adults, according to a study.

The interaction of hypertension and total plasma homocysteine (tHcy) levels contributes to the risk of all-cause mortality among middle-aged and older adults, a US study has found. In addition, hypertension may boost the ability of elevated tHcy to aggravate this risk.